Rezolute, Inc. RZLT
Set alert
3.95 USD -0.17 -4.13%
At close · Oct 30
3.92 -0.03 -0.76%
After hours · Oct 30, 6:09 PM ET
3.88 Day range 4.16
1.40 52-week range 10.94
- YTD
- +67.37%
- 1 year
- -59.78%
- Open
- 4.05
- Prev close
- 4.12
- Mkt cap
- 382.05M
- Vol
- 779.25K
- Avg vol
- 1.51M
- EPS
- -0.75
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.88
- High
- 4.16
- Forward P/E
- -3.42
- Beta
- 1.19
- Short ratio
- 3.16
- Inst. own
- 64.24%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.12
- 200-d avg
- 4.17
- 1y target
- 13.00
2Y chart
Events in this range
- Nov 5, 2024Rating: Wedbush · — → Outperform
- Nov 8, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (100)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 28, 2026 | 3 days ago |
| SMA: Bullish | Oct 27, 2026 | 4 days ago |
| SMA: Bearish | Oct 26, 2026 | 5 days ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 21, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 21, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| SMA: Bearish | Jul 29, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| SMA: Bearish | Jul 10, 2026 | 3 months ago |
| SMA: Bullish | Jul 9, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 2, 2026 | 4 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jun 30, 2026 | 4 months ago |
| RSI: Overbought | Jun 29, 2026 | 4 months ago |
| RSI: Overbought | Jun 17, 2026 | 4 months ago |
| RSI: Overbought | Jun 2, 2026 | 5 months ago |
| MACD: Buy Signal | May 26, 2026 | 5 months ago |
| MACD: Sell Signal | May 22, 2026 | 5 months ago |
| MACD: Buy Signal | May 21, 2026 | 5 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
| SMA: Bearish | May 19, 2026 | 5 months ago |
| MACD: Sell Signal | May 19, 2026 | 5 months ago |
| MACD: Buy Signal | May 14, 2026 | 5 months ago |
| SMA: Bullish | May 8, 2026 | 5 months ago |
| SMA: Bullish | Apr 30, 2026 | 6 months ago |
| SMA: Bearish | Apr 28, 2026 | 6 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 23, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 21, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 6 months ago |
| SMA: Bearish | Mar 27, 2026 | 7 months ago |
| SMA: Bullish | Mar 25, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 25, 2026 | 7 months ago |
| SMA: Bearish | Mar 12, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 13, 2026 | 8 months ago |
| RSI: Oversold | Jan 5, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 31, 2025 | 10 months ago |
| SMA: Bearish | Dec 11, 2025 | 10 months ago |
| SMA: Bearish | Dec 11, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 11, 2025 | 10 months ago |
| RSI: Oversold | Dec 11, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 8, 2025 | 10 months ago |
| SMA: Bullish | Dec 3, 2025 | 11 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 20, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 7, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 3, 2025 | 12 months ago |
| MACD: Buy Signal | Oct 27, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 23, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 22, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 6, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 24, 2025 | 1 year ago |
| RSI: Overbought | Sep 24, 2025 | 1 year ago |
| RSI: Overbought | Sep 18, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 15, 2025 | 1 year ago |
| RSI: Overbought | Aug 20, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 14, 2025 | 1 year ago |
| RSI: Overbought | Aug 13, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 1, 2025 | 1 year ago |
| RSI: Overbought | Jul 23, 2025 | 1 year ago |
| RSI: Overbought | Jul 16, 2025 | 1 year ago |
| RSI: Overbought | Jul 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 2, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 13, 2025 | 1 year ago |
| MACD: Buy Signal | May 28, 2025 | 1 year ago |
| MACD: Sell Signal | May 27, 2025 | 1 year ago |
| MACD: Buy Signal | May 21, 2025 | 1 year ago |
| MACD: Sell Signal | May 13, 2025 | 1 year ago |
| SMA: Bullish | Apr 23, 2025 | 1 year ago |
| RSI: Oversold | Apr 10, 2025 | 1 year ago |
| RSI: Oversold | Apr 3, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 2, 2025 | 1 year ago |
| RSI: Oversold | Mar 18, 2025 | 1 year ago |
| RSI: Oversold | Mar 10, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 10, 2025 | 1 year ago |
| SMA: Bullish | Jan 29, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 29, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 27, 2025 | 1 year ago |
| SMA: Bearish | Jan 24, 2025 | 1 year ago |
| SMA: Bullish | Jan 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 22, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 15, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 26, 2024 | 1 year ago |
| RSI: Oversold | Dec 18, 2024 | 1 year ago |
Key statistics
- Market cap
- 257.27M
- Enterprise value
- 192.07M
- Trailing P/E
- 0.00
- Forward P/E
- -3.42
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 1.95
- EPS (TTM)
- -1.27
- Beta
- 1.19
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -31.00M
- Total cash
- 126.87M
- Total debt
- 2.23M
- Return on equity
- -57.73%
- Shares outstanding
- 57.94M
- Short % of float
- 2.84%
- 50-day average
- 5.12
- 200-day average
- 4.17
Analyst view
Consensus: none
Price target (mean) 13.00 +229.1% upside
Now 3.95
- Target (low)
- 8.00
- Target (mean)
- 13.00
- Target (high)
- 16.00
Ratings (0m) 10 10 buy · 0 hold · 0 sell
- Strong buy3
- Buy7
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.26.
Financials — quick view
RZLT Revenue — quarterly 0
RZLT Net income — quarterly -20.49M
RZLT EPS — quarterly -0.20
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 8, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Nov 5, 2024 | Wedbush | init | — | Outperform |
| Aug 6, 2024 | Maxim Group | main | Buy | Buy |
| Aug 6, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Jul 17, 2024 | BTIG | init | — | Buy |
| Jun 4, 2024 | Craig-Hallum | init | — | Buy |
About Rezolute, Inc.
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. The company's lead product candidate is ersodetug, a human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 2 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- rezolutebio.com
News
- Rezolute (NASDAQ:RZLT) Stock Price Crosses Below 200-Day Moving Average – What’s Next?
- Rezolute Completes Enrollment In Open-Label Phase 3 Study Of Ersodetug In Tumor HI; Topline Data Expected In Mid-December 2026
- Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
- Rezolute, Inc. (NASDAQ:RZLT) Stock Now Rated “Moderate Buy” by Sell-Side Analysts
- This NetApp Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
- Lake Street Maintains Buy on Rezolute, Raises Price Target to $12
- Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $15
- This Boyd Gaming Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
- FDA Recommends Meeting for Rezolute Drug for Rare Blood Sugar Disorder Despite Missed Endpoints
- Rezolute (NASDAQ:RZLT) Stock Sees Unusually High Call Option Buying
Your note
Sign in to keep a note on RZLT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ELAM NEVAN C | Chief Executive Officer | Purchase | Feb 25, 2024 | 7,817 |
| EVANS DARON | Chief Financial Officer | Purchase | Dec 17, 2024 | 232,900 |
| HOGENHUIS WLADIMIR | Director | Purchase | Sep 23, 2024 | 41,767 |
| KIM YOUNG-JIN | Director | Purchase | Mar 6, 2024 | 6,058,070 |
| ROBERTS BRIAN KENNETH | Officer | Purchase | Jun 13, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vivo Capital, LLC | 33.23% | 2,797,704 | 12.42M | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 30.61% | 2,577,121 | 11.44M | Sep 29, 2024 |
| Vanguard Group Inc | 22.95% | 1,932,057 | 8.58M | Sep 29, 2024 |
| Blackstone Inc | 20.73% | 1,744,740 | 7.75M | Sep 29, 2024 |
| Affinity Asset Advisors, Llc | 20.19% | 1,700,000 | 7.55M | Sep 29, 2024 |
| Altium Capital Management, LP | 20.19% | 1,700,000 | 7.55M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Federated Hermes Kaufmann Fund | 45.44% | 3,825,000 | 16.98M | Jul 30, 2024 |
| Federated Hermes Kaufmann Small Cap Fund | 45.29% | 3,812,860 | 16.93M | Jul 30, 2024 |
| Vanguard Total Stock Market Index Fund | 12.85% | 1,081,601 | 4.80M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 9.06% | 762,525 | 3.39M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 3.10% | 260,618 | 1.16M | Oct 30, 2024 |
| iShares Micro Cap ETF | 1.22% | 103,090 | 457.72K | Oct 30, 2024 |